A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 1,410 followers.

A critical appraisal of ibrutinib in treatment of mantle cell lymphoma and chronic lymphocytic leukemia http://t.co/XY6FZZWrq7 @MCLPlymouth

A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and… http://t.co/SyaKdIN6jc #leukemia http://t.co/vsiuntMS5j

Ibrutinib for MCL and CLL http://t.co/YUl4bfiwEl

Ibrutinib for MCL and CLL http://t.co/NP7F0uygKd

Ibrutinib for MCL and CLL http://t.co/4KDHJjUURJ